UPDATE 3-Teva to buy Allergan generic drug business for $40.5 bln, drops Mylan bid
July 27, 2015 at 07:48 AM EDT
* Combined entity to have proforma revenue of $26 bln in 2016
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.